A citation-based method for searching scientific literature

Frank O Nestle, Daniel H Kaplan, Jonathan Barker. N Engl J Med 2009
Times Cited: 1860







List of co-cited articles
521 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Psoriasis.
Wolf-Henning Boehncke, Michael P Schön. Lancet 2015
21

Pathogenesis and clinical features of psoriasis.
Christopher Em Griffiths, Jonathan Nwn Barker. Lancet 2007
13

Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.
Leslie van der Fits, Sabine Mourits, Jane S A Voerman, Marius Kant, Louis Boon, Jon D Laman, Ferry Cornelissen, Anne-Marie Mus, Edwin Florencia, Errol P Prens,[...]. J Immunol 2009
13

Psoriasis and comorbid diseases: Epidemiology.
Junko Takeshita, Sungat Grewal, Sinéad M Langan, Nehal N Mehta, Alexis Ogdie, Abby S Van Voorhees, Joel M Gelfand. J Am Acad Dermatol 2017
383
12


Immunology of psoriasis.
Michelle A Lowes, Mayte Suárez-Fariñas, James G Krueger. Annu Rev Immunol 2014
845
12

Global epidemiology of psoriasis: a systematic review of incidence and prevalence.
Rosa Parisi, Deborah P M Symmons, Christopher E M Griffiths, Darren M Ashcroft. J Invest Dermatol 2013
11

A systematic review of worldwide epidemiology of psoriasis.
I M Michalek, B Loring, S M John. J Eur Acad Dermatol Venereol 2017
354
11

The IL-23/Th17 axis in the immunopathogenesis of psoriasis.
Antonella Di Cesare, Paola Di Meglio, Frank O Nestle. J Invest Dermatol 2009
735
11

Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis.
Jason E Hawkes, Bernice Y Yan, Tom C Chan, James G Krueger. J Immunol 2018
209
10

Psoriasis Pathogenesis and Treatment.
Adriana Rendon, Knut Schäkel. Int J Mol Sci 2019
375
10

Psoriasis.
Christopher E M Griffiths, April W Armstrong, Johann E Gudjonsson, Jonathan N W N Barker. Lancet 2021
139
10

Pathogenesis and therapy of psoriasis.
Michelle A Lowes, Anne M Bowcock, James G Krueger. Nature 2007
9

Psoriasis pathogenesis and the development of novel targeted immune therapies.
Jason E Hawkes, Tom C Chan, James G Krueger. J Allergy Clin Immunol 2017
374
9

Psoriasis.
Jacqueline E Greb, Ari M Goldminz, James T Elder, Mark G Lebwohl, Dafna D Gladman, Jashin J Wu, Nehal N Mehta, Andrew Y Finlay, Alice B Gottlieb. Nat Rev Dis Primers 2016
337
8

Definition of treatment goals for moderate to severe psoriasis: a European consensus.
U Mrowietz, K Kragballe, K Reich, P Spuls, C E M Griffiths, A Nast, J Franke, C Antoniou, P Arenberger, F Balieva,[...]. Arch Dermatol Res 2011
493
7

Secukinumab in plaque psoriasis--results of two phase 3 trials.
Richard G Langley, Boni E Elewski, Mark Lebwohl, Kristian Reich, Christopher E M Griffiths, Kim Papp, Lluís Puig, Hidemi Nakagawa, Lynda Spelman, Bárður Sigurgeirsson,[...]. N Engl J Med 2014
7

Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production.
Frank O Nestle, Curdin Conrad, Adrian Tun-Kyi, Bernhard Homey, Michael Gombert, Onur Boyman, Günter Burg, Yong-Jun Liu, Michel Gilliet. J Exp Med 2005
771
7

National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study.
Rosa Parisi, Ireny Y K Iskandar, Evangelos Kontopantelis, Matthias Augustin, Christopher E M Griffiths, Darren M Ashcroft. BMJ 2020
133
7

Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.
Kenneth B Gordon, Andrew Blauvelt, Kim A Papp, Richard G Langley, Thomas Luger, Mamitaro Ohtsuki, Kristian Reich, David Amato, Susan G Ball, Daniel K Braun,[...]. N Engl J Med 2016
460
6

Psoriasis--epidemiology and clinical spectrum.
E Christophers. Clin Exp Dermatol 2001
562
6

Psoriasis.
Paola Di Meglio, Federica Villanova, Frank O Nestle. Cold Spring Harb Perspect Med 2014
146
6

The immunopathogenesis of psoriasis.
Jaehwan Kim, James G Krueger. Dermatol Clin 2015
182
6

Severe psoriasis--oral therapy with a new retinoid.
T Fredriksson, U Pettersson. Dermatologica 1978
6

Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells.
Michelle A Lowes, Toyoko Kikuchi, Judilyn Fuentes-Duculan, Irma Cardinale, Lisa C Zaba, Asifa S Haider, Edward P Bowman, James G Krueger. J Invest Dermatol 2008
732
6

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.
Alan Menter, Alice Gottlieb, Steven R Feldman, Abby S Van Voorhees, Craig L Leonardi, Kenneth B Gordon, Mark Lebwohl, John Y M Koo, Craig A Elmets, Neil J Korman,[...]. J Am Acad Dermatol 2008
852
5


A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis.
K A Papp, K Reich, C Paul, A Blauvelt, W Baran, C Bolduc, D Toth, R G Langley, J Cather, A B Gottlieb,[...]. Br J Dermatol 2016
279
5

Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities.
Craig A Elmets, Craig L Leonardi, Dawn M R Davis, Joel M Gelfand, Jason Lichten, Nehal N Mehta, April W Armstrong, Cody Connor, Kelly M Cordoro, Boni E Elewski,[...]. J Am Acad Dermatol 2019
131
5

Psoriasis.
Gayathri K Perera, Paola Di Meglio, Frank O Nestle. Annu Rev Pathol 2012
348
5

Psoriasis.
Michael P Schön, W-Henning Boehncke. N Engl J Med 2005
834
5

Psoriasis and smoking: a systematic review and meta-analysis.
A W Armstrong, C T Harskamp, J S Dhillon, E J Armstrong. Br J Dermatol 2014
139
5

Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants.
Lam C Tsoi, Philip E Stuart, Chao Tian, Johann E Gudjonsson, Sayantan Das, Matthew Zawistowski, Eva Ellinghaus, Jonathan N Barker, Vinod Chandran, Nick Dand,[...]. Nat Commun 2017
131
5

Psoriasis and the metabolic syndrome.
Paolo Gisondi, Anna Chiara Fostini, Irene Fossà, Giampiero Girolomoni, Giovanni Targher. Clin Dermatol 2018
114
5

The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis.
Roberto Lande, Elisabetta Botti, Camilla Jandus, Danijel Dojcinovic, Giorgia Fanelli, Curdin Conrad, Georgios Chamilos, Laurence Feldmeyer, Barbara Marinari, Susan Chon,[...]. Nat Commun 2014
300
5

Scanning the Immunopathogenesis of Psoriasis.
Andrea Chiricozzi, Paolo Romanelli, Elisabetta Volpe, Giovanna Borsellino, Marco Romanelli. Int J Mol Sci 2018
115
5

Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis.
Yan Zheng, Dimitry M Danilenko, Patricia Valdez, Ian Kasman, Jeffrey Eastham-Anderson, Jianfeng Wu, Wenjun Ouyang. Nature 2007
5

Prevalence of psoriasis in China: a population-based study in six cities.
Xiaolan Ding, Tinglin Wang, Yiwei Shen, Xiaoyan Wang, Cheng Zhou, Shan Tian, Ying Liu, Guanghui Peng, June Zhou, Shuqi Xue,[...]. Eur J Dermatol 2012
110
4

Analysis of long non-coding RNAs highlights tissue-specific expression patterns and epigenetic profiles in normal and psoriatic skin.
Lam C Tsoi, Matthew K Iyer, Philip E Stuart, William R Swindell, Johann E Gudjonsson, Trilokraj Tejasvi, Mrinal K Sarkar, Bingshan Li, Jun Ding, John J Voorhees,[...]. Genome Biol 2015
151
4

The immunogenetics of Psoriasis: A comprehensive review.
Jamie L Harden, James G Krueger, Anne M Bowcock. J Autoimmun 2015
295
4

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial.
Alan Menter, Stephen K Tyring, Kenneth Gordon, Alexa B Kimball, Craig L Leonardi, Richard G Langley, Bruce E Strober, Martin Kaul, Yihua Gu, Martin Okun,[...]. J Am Acad Dermatol 2008
628
4

Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis.
Kim A Papp, Andrew Blauvelt, Michael Bukhalo, Melinda Gooderham, James G Krueger, Jean-Philippe Lacour, Alan Menter, Sandra Philipp, Howard Sofen, Stephen Tyring,[...]. N Engl J Med 2017
285
4

Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: A Phase 3 Randomized Clinical Trial.
Andrew Blauvelt, Craig L Leonardi, Melinda Gooderham, Kim A Papp, Sandra Philipp, Jashin J Wu, Atsuyuki Igarashi, Mary Flack, Ziqian Geng, Tianshuang Wu,[...]. JAMA Dermatol 2020
53
7

Japanese guidelines for the management and treatment of generalized pustular psoriasis: The new pathogenesis and treatment of GPP.
Hideki Fujita, Tadashi Terui, Koremasa Hayama, Masashi Akiyama, Shigaku Ikeda, Tomotaka Mabuchi, Akira Ozawa, Takuro Kanekura, Michiko Kurosawa, Mayumi Komine,[...]. J Dermatol 2018
67
5

Update on psoriasis immunopathogenesis and targeted immunotherapy.
Satveer K Mahil, Francesca Capon, Jonathan N Barker. Semin Immunopathol 2016
116
4

Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis.
Kim Papp, Kenneth Gordon, Diamant Thaçi, Akimichi Morita, Melinda Gooderham, Peter Foley, Ihab G Girgis, Sudeep Kundu, Subhashis Banerjee. N Engl J Med 2018
158
4

Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model.
Shigetoshi Sano, Keith Syson Chan, Steve Carbajal, John Clifford, Mary Peavey, Kaoru Kiguchi, Satoshi Itami, Brian J Nickoloff, John DiGiovanni. Nat Med 2005
517
4

Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis.
Andrea Chiricozzi, Emma Guttman-Yassky, Mayte Suárez-Fariñas, Kristine E Nograles, Suyan Tian, Irma Cardinale, Sergio Chimenti, James G Krueger. J Invest Dermatol 2011
402
4

Targeting CD8(+) T cells prevents psoriasis development.
Paola Di Meglio, Federica Villanova, Alexander A Navarini, Alessio Mylonas, Isabella Tosi, Frank O Nestle, Curdin Conrad. J Allergy Clin Immunol 2016
76
5

Psoriasis: A STAT3-Centric View.
Enzo Calautti, Lidia Avalle, Valeria Poli. Int J Mol Sci 2018
85
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.